Fred Alger Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48,481	Closed	-$767K	–	450
2024 Q4	$767K	Sell	48,481 -10,657	-18%	-$169K	﹤0.01%	371
2024 Q3	$3.43M	Buy	59,138 +10,145	+21%	+$589K	0.02%	282
2024 Q2	$2.24M	Sell	48,993 -16,887	-26%	-$772K	0.01%	313
2024 Q1	$4.36M	Buy	+65,880	New	+$4.36M	0.02%	271